Effects of mu- and delta-opioid-receptor antagonists on the stimulus properties of cholecystokinin (Q44345824)

2 December 2017

title

Effects of mu- and delta-opioid-receptor antagonists on the stimulus properties of cholecystokinin (English)

1 reference

2 December 2017

0 references

1 reference

A L Riley

1

1 reference

2 December 2017

P M Melton

series ordinal

2

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

Pharmacology, Biochemistry and Behavior

2 December 2017

published in

1 reference

2 December 2017

volume

57

1 reference

2 December 2017

issue

1-2

1 reference

2 December 2017

page(s)

57-62

1 reference

Effects of the benzomorphan kappa-opiate, MR 2266 and its (+) enantiomer MR 2267, on thermonociceptive reactions in different strains of mice

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Brain cholecystokinin and beta-endorphin systems may antagonistically interact to regulate tissue DNA synthesis in rat pups

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solution

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

[3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

The highly selective delta agonist BUBU induces an analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Opiate antagonistic function of cholecystokinin in analgesia and energy balance systems

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Intracerebroventricular cholecystokinin infusions block beta-endorphin-induced disruption of maternal behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Differential effects of the CCK antagonist, MK-329, on analgesia induced by morphine, social conflict (opioid) and defeat experience (non-opioid) in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Effects of .BETA.-endorphin, thyrotropin-releasing hormone and cholecystokinin on body shaking behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Cholecystokinin interferes with the thermoregulatory effect of exogenous and endogenous opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

In vivo binding of N1'-([11C]methyl)naltrindole to delta-opioid receptors in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Endogenous opioid peptides: multiple agonists and receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Discriminative properties of morphine that modulate associations between tastes and lithium chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Conditioned taste aversions as a behavioral baseline for drug discrimination learning: an assessment with phencyclidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Cholecystokinin as a stimulus in drug discrimination learning.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

An assessment of the interaction between cholecystokinin and the opiates within a drug discrimination procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Receptor mediation of the stimulus properties of cholecystokinin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

In vitro, release of cholecystokinin from hypothalamus and frontal cortex of Sprague-Dawley, Zucker lean (Fa/-) and obese (fa/fa) rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Opiate-mediated inhibition of the release of cholecystokinin and substance P, but not neurotensin from cat hypothalamic slices

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Studies on the opiate receptor-mediated inhibition of K+-stimulated cholecystokinin and substance P release from cat hypothalamus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Effect of opiates on the release of cholecystokinin from in vitro hypothalamus and frontal cortex of Zucker lean (Fa/-) and obese (fa/fa) rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Effect of the kappa-receptor agonist, U-50,488H, on cerebral ischemia-induced impairment of working memory assessed in rats by a three-panel runway task

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Buprenorphine as a stimulus in drug discrimination learning: an assessment of mu and kappa receptor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Failure of cholecystokinin to precipitate withdrawal in morphine-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

CCK receptor activation may prevent tolerance to morphine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Buprenorphine is an Antagonist at the ϰ Opioid Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

The effects of chronic morphine on the generalization of buprenorphine stimulus control: an assessment of kappa antagonist activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Effects of cholecystokinin on morphine-elicited hyperactivity in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Cholecystokinin antagonizes morphine induced hypoactivity and hyperactivity in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Opioid receptor binding properties of analgesic analogues of cholecystokinin octapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Attenuation of the discriminative stimulus properties of cocaine by delta-opioid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

The role of delta-opioid receptor subtypes in cocaine- and methamphetamine-induced place preferences

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Blockade of delta-opioid receptors prevents morphine-induced place preference in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Pharmacological manipulation of sincalide (CCK-8)-induced suppression of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

The kappa-opioid receptor: evidence for the different subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Multiple opiate receptors: Support for unique mu, delta and kappa sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900119-0

7 January 2021

10.1016/S0091-3057(96)00119-0

Identifiers

DOI

1 reference

2 December 2017

1 reference